Z-0216-2024 Class II Ongoing

Recalled by Cepheid — Sunnyvale, CA

FDA device recall Z-0216-2024 was initiated by Cepheid on Apr 24, 2023 and is designated Class II. Reason for recall: pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results. The recall status is ongoing. Affected quantity: 1,413 kits ( 10 test per kit).

Recall details

Product Type
Devices
Report Date
Nov 8, 2023
Initiation Date
Apr 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,413 kits ( 10 test per kit)

Product description

Xpert Xpress Strep A, REF:Xprstrepa-CE-10, CE IVD,

Reason for recall

pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Costa Rica, Ireland, Estonia, United Kingdom, Germany, Italy, Greece, Poland, Switzerland, Hong Kong, United Arab Emirates.

Code information

UDI: (01)07332940006297/ Lot: 23815

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0216-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0216-2024. Report a data issue: hello@regdatalab.com.